Emergent BioSolutions completes $75 million note repurchase
Emergent BioSolutions (EBS) completed the repurchase of $75 million aggregate principal amount of senior unsecured notes.
Story updates
11:47:43 AM UTC
SquawkNews
GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. NYSE:EBS today announced that it has completed the repurchase of $75 million aggregate principal amount of its 3.875% Senior Unsecured Notes due 2028 (the “Senior Unsecured Notes”), following authorization granted by i…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.